1. bookVolumen 60 (2017): Heft 3 (October 2017)
30 Mar 2015
4 Hefte pro Jahr
Uneingeschränkter Zugang

Hyperbaric Oxygen Therapy (HBOT) as a Therapeutic Option for Patients with Atopic Dermatitis (AD) – Own Experiences and Literature Review

Online veröffentlicht: 30 Nov 2017
Volumen & Heft: Volumen 60 (2017) - Heft 3 (October 2017)
Seitenbereich: 13 - 18
Eingereicht: 13 Dec 2011
Akzeptiert: 07 May 2017
30 Mar 2015
4 Hefte pro Jahr

1. Mathieu D, Marroni A, Kot J (2017) Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and nonaccepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med, 47(1): 24-32. PMID: 28357821;10.28920/dhm47.2.131-132614775528641327Search in Google Scholar

2. Thom SR (2011) Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg, 127 (Suppl 1): 131S-141S. DOI:10.1097/PRS.0b013e3181fbe2bf;10.1097/PRS.0b013e3181fbe2bf305832721200283DOI öffnenSearch in Google Scholar

3. Kierznikowicz B, Ulewicz K (1976) Influence of oxygen hyperbaria on the activity of complement in human’s sera. Acta Physiol Pol, 27: 409-411. PMID: 983722;Search in Google Scholar

4. Hansbrough JF, Piacentine JG, Eiseman B (1980) Immunosuppression by hyperbaric oxygen. Surgery, 87: 662-667. PMID: 7376077;Search in Google Scholar

5. Ulewicz K, Zannini D (1986) On the possibility of hyperbaric oxygen therapy in some pathological reactions of immunological hypersensitivity. Bull Inst Mar Trop Med Gdynia, 37 (1-2): 71-79. PMID: 3555661;Search in Google Scholar

6. Saito K, Tanaka Y, Ota T, Eto S, Yamashita U (1991) Suppressive effect of hyperbaric oxygenation on immune responses of normal and autoimmune mice. Clin Exp Immunol, 86: 322-327. DOI: 10.1111/j.1365-2249.1991.tb05817.x;10.1111/j.1365-2249.1991.tb05817.x15541111934599DOI öffnenSearch in Google Scholar

7. Olszański R, Pachut M, Sićko Z, Sztaba-Kania M, Wilkowska A (1992) Efficacy of hyperbaric oxygenation in atopic dermatitis. Bull Inst Mar Trop Med Gdynia, 43 (1-4): 79-82. PMID: 1345603;Search in Google Scholar

8. Di Cesare A, Di Meglio P, Nestle FO (2008) A role for Th17 cells in the immunopathogenesis of atopic dermatitis ? J Invest Dermatol, 128: 2569-2571. DOI: 10.1038/jid.2008.283;Search in Google Scholar

9. Kudchodkar BJ, Jones H, Simecka J, Dory L (2008) Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice. Clin Immunol, 128(3): 435-441. DOI:10.1016/j.clim.2008.05.004;10.1016/j.clim.2008.05.004256253318595776DOI öffnenSearch in Google Scholar

10. Hultqvist M, Olsson LM, Gelderman KA, Holmdahl R (2009) The protective role of ROS in autoimmune disease. Trends Immunol, 30: 201-208. DOI:10.1016/j.it.2009.03.004;Search in Google Scholar

11. Kim HR, Kim JH, Choi EJ, Lee YK, Kie JH, Jang MH, Seoh JY (2014) Hyperoxygenation attenuated a murine model of Atopic Dermatitis through raising skin level of ROS. PLoS ONE, 9 (10): e109297. DOI: 10.1371/journal.pone.0109297;Search in Google Scholar

12. Berke R, Singh A, Guralnick M (2012) Atopic dermatitis: an overview. Am Fam Physician, 86: 35-42. PMID: 22962911;Search in Google Scholar

13. Nowicki R, Trzeciak M, Wilkowska A, Sokołowska-Wojdyło M, Ługowska-Umer H, Barańska-Rybak W, Kaczmarski M, Kowalewski C, Kruszewski J, Maj J, Silny W, Śpiewak R, Petranyuk A (2015) Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Postep Derm Alergol, 32 (4): 239-249. DOI: 10.5114/pdia.2015.53319;10.5114/pdia.2015.53319456583826366146DOI öffnenSearch in Google Scholar

14. Won HY, Sohn JH, Min HJ, Lee K, Woo HA, Ho YS, Park JW, Rhee SG, Hwang ES (2010) Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing Th2 and Th17 cell development. Antioxid Redox Signal, 13: 575-587. DOI: 10.1089/ars.2009.2989;10.1089/ars.2009.298920367278DOI öffnenSearch in Google Scholar

15. Erdmann D, Roth AC, Hussmann J, Lyons SF, Mody NJ, Kucan JO, Russell RC (1995) Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice. Undersea Hyperb Med 22: 395-399. PMID: 8574127;Search in Google Scholar

16. Kudchodkar BJ, Wilson J, Lacko A, Dory L (2000) Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol, 20: 1637-1643. DOI: 10.1161/01.ATV.20.6.1637;10.1161/01.ATV.20.6.163710845883DOI öffnenSearch in Google Scholar

17. Akin ML, Gulluoglu BM, Uluutku H, Erenoglu C, Elbuken E, Yildirim S, Celenk T (2002) Hyperbaric oxygen improves healing in experimental rat colitis. Undersea Hyperb Med, 29: 279-285. PMID: 12797669;Search in Google Scholar

18. Benson RM, Minter LM, Osborne BA (2003) Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human bloodderived monocyte-macrophages. Clin Exp Immunol, 134: 57-62. DOI: 10.1046/j.1365-2249.2003.02248.x;10.1046/j.1365-2249.2003.02248.x180884312974755DOI öffnenSearch in Google Scholar

19. Butler G, Michaels JC, Al-Waili N, Finkelstein M, Allen M, Petrillo R, Carrey Z, Kolanuvada B, Lee BY, Riera AG, Michaels CC, Urteaga G (2009) Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: two case reports and a review of the literature. J Med Case Rep, 3: 7023. DOI: 10.4076/1752-1947-3-702310.4076/1752-1947-3-7023DOI öffnenSearch in Google Scholar

20. Olivieri AN, Mellos A, Duilio C, Di Meglio M, Mauro A, Perrone L (2010) Refractory vasculitic ulcer of the toe in adolescent suffering fromSystemic Lupus Erythematosus treated successfully with hyperbaric oxygen therapy. Ital J Pediatr, 36: 72. DOI:10.1186/1824-7288-36-72; 10.1186/1824-7288-36-72298880721040521DOI öffnenSearch in Google Scholar

21. Faleo G, Fotino C, Bocca N, Molano RD, Zahr-Akrawi E, Molina J, Villate S, Umland O, Skyler JS, Bayer AL, Ricordi C, Pileggi A (2012)Prevention of autoimmune diabetes and induction of beta-cell proliferation in NOD mice by hyperbaric oxygen therapy. Diabetes, 61: 1769-1778. DOI: 10.2337/db11-0516; 10.2337/db11-0516DOI öffnenSearch in Google Scholar

22. Jacob BB, Thuning CA, Sacksteder MR, Warren JM (1979) Extended skin allograft survival in mice during prolonged exposure to hyperbaric oxygen. Transplantation 28: 70-72. PMID: 377598;10.1097/00007890-197907000-00017Search in Google Scholar

23. Granowitz EV, Skulsky EJ, Benson RM, Wright J, Garb JL, Cohen ER, Smithline EC, Brown RB (2002) Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea Hyperb Med, 29: 216-225. PMID: 12670123;Search in Google Scholar

24. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z (2006) Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab, 26: 666-674. DOI: 10.1038/sj.jcbfm.9600221;10.1038/sj.jcbfm.9600221DOI öffnenSearch in Google Scholar

25. Zhang J, Fife CE, Currie MS, Moon RE, Piantadosi CA, Vann RD (1991) Venous gas emboli and complement activation after deep repetitive air diving. Undersea Biomed Res, 18 (4): 293-302. PMID: 1887517;Search in Google Scholar

26. Pekna M, Ersson A (1996) Complement system response to decompression. Undersea Hyperb Med, 23 (1): 31-34. PMID: 8653063;Search in Google Scholar

27. Konarski M, Olszański R, Baj Z, Buczyński A, Kłos R, Skrzyński S (2000) [Influence of air hyperbaric exposures on selected haematological parameters and complement system] [Article in Polish]. Pol Przegl Med Lot, 6 (1): 25-31. ISSN 1233-0779;Search in Google Scholar

28. Olszański R, Konarski M, Kierznikowicz B (2002) Changes of selected morphotic parameters and blood plasma proteins in blood of divers after a single short-time operational heliox exposure. Int Marit Health, 53 (1-4): 111-121. PMID: 12608594;Search in Google Scholar

29. Kłos R, Konarski M, Olszański R (2004) The implementation of factor analysis for the evaluation of selected blood parameter changes induced by hyperbaric exposure. Int Marit Health, 55 (1-4): 87-102. PMID: 15881546;Search in Google Scholar

30. Nyquist P, Ball R, Sheridan MJ (2007) Complement levels before and after dives with a high risk of DCS. Undersea Hyperb Med, 34 (3): 191-197. PMID: 17672175;Search in Google Scholar

31. Warren J, Sacksteder MR, Thuning CA (1978) Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents. J Immunol, 121 (1): 315-320. PMID: 670704;10.4049/jimmunol.121.1.315Search in Google Scholar

32. Bokeriia LA, Frolova MA, Kostava VT (1979) [Suppression of humoral antibody synthesis on exposure to hyperbaric oxygenation] [Article in Russian, English abstract]. Biull Eksp Biol Med, 87 (4): 320-322. PMID: 571294;10.1007/BF00804411Search in Google Scholar

33. Bean JW, Smith CW (1952) Hypophyseal and adrenocortical factors in pulmonary damage induced by oxygen at atmospheric pressure. Am J Physiol, 172: 169-174. PMID: 13030734;10.1152/ajplegacy.1952.172.1.169Search in Google Scholar

34. Houlihan RT, WeinerRE, Zavodni J (1966) Adrenocortical response to stimulated high altitude and to oxygen at high pressures. Physiologist, 9: 206 [abstract];Search in Google Scholar

35. Brenner I, Shephard RJ, Shek PN (1999) Immune function in hyperbaric environments, diving, and decompression. Undersea Hyperb Med, 26 27-39. PMID: 10353182;Search in Google Scholar

36. Garthwaite J (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci, 14: 60-67. DOI: 10.1016/0166- 2236(91)90022-M;10.1016/0166-2236(91)90022-DOI öffnenSearch in Google Scholar

37. Bredt DS, Snyder SH (1992) Nitric oxide, a novel neuronal messenger. Neuron, 8: 3-11. DOI: 10.1016/0896-6273(92)90104-L;10.1016/0896-6273(92)90104-DOI öffnenSearch in Google Scholar

38. Inamoto Y, Okuno F, Saito K, Tanaka Y, Watanabe K, Morimoto I, Yamashita U, Eto S (1991) Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Commun, 179: 886-891. DOI: 10.1016/0006-291X(91)91901-N;10.1016/0006-291X(91)91901-DOI öffnenSearch in Google Scholar

39. Mialon P, Barthelemy L (1993) Effect of hyperbaric oxygen on prostaglandin and thromboxane synthesis in the cortex and the striatum of rat brain. Mol Chem Neuropathol, 20: 181-189. DOI: 10.1007/BF02815371;10.1007/BF028153718297421DOI öffnenSearch in Google Scholar

40. Yang ZJ, Bosco G, Montante A, Ou XI, Camporesi EM (2001) Hyperbaric O2 reduces intestinal ischemia-reperfusion-induced TNF-alpha production and lung neutrophil sequestration. Eur J Appl Physiol 85: 96-103. DOI: 10.1007/s004210100503;10.1007/s00421010050311820317DOI öffnenSearch in Google Scholar

41. Şen H, Erbağ G, Ovali MA, Oztopuz RO, Uzun M (2016) Investigation of endocrine and immunological response in fat tissue to hyperbaric oxygen administration in rats. Cell Mol Biol (Noisy-le-grand), 62 (5): 15-19. PMID: 27188864Search in Google Scholar

42. Yin W, Badr AE, Mychaskiw G, Zhang JH (2002) Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Brain Res, 926: 165-171. DOI: 10.1016/S0006-8993(01)03304-2;10.1016/S0006-8993(01)03304-2DOI öffnenSearch in Google Scholar

43. de Vries JE (1995) Immunosuppressive and anti-inflammatory properties of IL-10. Ann Med, 27: 537-541. DOI: 10.3109/07853899509002465;Search in Google Scholar

44. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW (1990) Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg, 160: 519-524. DOI: 10.1016/S0002-9610(05)81019-0;10.1016/S0002-9610(05)81019-0DOI öffnenSearch in Google Scholar

45. Luongo C, Imperatore F, Cuzzocrea S, Filippelli A, Scafuro MA, Mangoni G, Portolano F, Rossi F (1998) Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med, 26: 1972-1976. DOI: 10.1097/00003246-199812000-00022;10.1097/00003246-199812000-00022DOI öffnenSearch in Google Scholar

46. Xu X, Yi H, Kato M, Suzuki H, Kobayashi S, Takahashi H, Nakashima I (1997) Differential sensitivities to hyperbaric oxygen of lymphocyte subpopulations of normal and autoimmune mice. Immunol Lett, 59: 79-84. DOI: 10.1016/S0165-2478(97)00104-1;10.1016/S0165-2478(97)00104-1DOI öffnenSearch in Google Scholar

47. Takeshima F, Makiyama K, Doi T (1999) Hyperbaric oxygen as adjunct therapy for Crohn’s intractable enteric ulcer. Am J Gastroenterol, 94: 3374-3375. DOI: 10.1111/j.1572-0241.1999.03374.x;10.1111/j.1572-0241.1999.03374.xDOI öffnenSearch in Google Scholar

48. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J (2001) Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol, 33: 337-339. DOI: 10.1097/00004836-200110000-00018;10.1097/00004836-200110000-00018DOI öffnenSearch in Google Scholar

49. Freeman BA, Crapo JD (1981) Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem, 256: 10986-10992. PMID: 7287745;10.1016/S0021-9258(19)68544-3Search in Google Scholar

50. Jamieson D, Chance B, Cadenas E, Boveris A (1986) The relation of free radical production to hyperoxia. Annu Rev Physiol, 48: 703-719. DOI: 10.1146/annurev.ph.48.030186.003415;10.1146/annurev.ph.48.030186.003415DOI öffnenSearch in Google Scholar

51. Jamieson D (1991) Lipid peroxidation in brain and lungs from mice exposed to hyperoxia. Biochem Pharmacol, 41: 749-756. DOI: 10.1016/0006-2952(91)90076-H;10.1016/0006-2952(91)90076-DOI öffnenSearch in Google Scholar

52. Dennog C, Radermacher P, Barnett YA, Speita G (1999) Antioxidant status in humans after exposure to hyperbaric oxygen. Mutation Res, 428: 83-89. DOI: 10.1016/S1383-5742(99)00034-4; 10.1016/S1383-5742(99)00034-4DOI öffnenSearch in Google Scholar

53. Thom SR (2009) Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol, 106: 988-995. DOI: 10.1152/japplphysiol.91004.2008;10.1152/japplphysiol.91004.2008266025218845776DOI öffnenSearch in Google Scholar

54. George-Chandy A, Nordstrom I, Nygren E, Jonsson IM, Postigo J, Collins LV, Eriksson K (2008) Th17 development and autoimmune arthritis in the absence of reactive oxygen species. Eur J Immunol, 38: 1118-1126. DOI: 10.1002/eji.200737348;10.1002/eji.20073734818383034DOI öffnenSearch in Google Scholar

55. Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Bergd JM, Ottenhoff THM, Kuijpers TW, Holmdahle R, van Kootena C, Geldermana KA (2010) Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci USA, 107: 17686-17691. DOI:10.1073/pnas.1012016107/-/DCSupplemental;10.1073/pnas.1012016107/-/DCSupplementalDOI öffnenSearch in Google Scholar

56. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, Luo W, Zeller K, Shimoda L, Topalian SL, Semenza GL, Dang CV, Pardoll DM, Pan F (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell, 146: 772-784. DOI: 10.1016/j.cell.2011.07.033;10.1016/j.cell.2011.07.033338767821871655DOI öffnenSearch in Google Scholar

57. Munn DH, Mellor AL (2013) Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol, 34: 137-143. DOI: 10.1016/j.it.2012.10.001;10.1016/j.it.2012.10.001359463223103127DOI öffnenSearch in Google Scholar

58. Lee K, Won HY, Bae MA, Hong JH, Hwang ES (2011) Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells. Proc Natl Acad Sci USA, 108: 9548-9553. DOI: 10.1073/pnas.1012645108;10.1073/pnas.1012645108311132821593419DOI öffnenSearch in Google Scholar

59. Won HY, Jang EJ, Lee K, Oh S, Kim HK, Woo HA, Kang SW, Yu DY, Rhee SG, Hwang ES (2013) Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells. J Immunol, 191: 4029-4037. DOI: 10.4049/jimmunol.1203247;10.4049/jimmunol.120324724048895DOI öffnenSearch in Google Scholar

60. Olszański R, Konarski M, Kłos R, Siermontowski P (1999) [Oxygen exposures and diver's safety] [Article in Polish]. Lek Wojsk, 75 (1-2): 71-77. ISSN: 0024-0745;Search in Google Scholar

61. Kleen M, Messmer K (1999) Toxicity of high PaO2. Minerva Anestesiol, 65: 393-396. PMID: 10394808; 62. Torbati D, Church DF, Keller JM, Pryor WA (1992) Free radical generation in the brain precedes hyperbaric oxygen-induced convulsions. Free Radic Biol Med, 13: 101-106. DOI: 10.1016/0891-5849(92)90070-W;Search in Google Scholar

63. Thom SR, Bhopale V, Fisher D, Manevich Y, Huang PL, Buerk DG (2002) Stimulation of nitric oxide synthase in cerebral cortex due to elevated partial pressures of oxygen: an oxidative stress response. J Neurobiol, 51: 85-100. DOI: 10.1002/neu.10044;10.1002/neu.1004411932951DOI öffnenSearch in Google Scholar

64. Harabin AL, Braisted JC, Flynn ET (1990) Response of antioxidant enzymes to intermittent and continuous hyperbaric oxygen. J Appl Physiol, 69: 328-635. PMID: 2394655;10.1152/jappl.1990.69.1.3282394655Search in Google Scholar

65. Narkowicz CH, Vial JH, McCartney PW (1993) Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun, 19: 71-80. DOI: 10.3109/10715769309056501;10.3109/107157693090565018225040DOI öffnenSearch in Google Scholar

66. Dennog C, Hartmann A, Frey G, Speit G (1996) Detection of DNA damage after hyperbaric oxygen (HBO) therapy. Mutagenesis, 11: 605-609. DOI: 10.1093/mutage/11.6.605.10.1093/mutage/11.6.6058962431DOI öffnenSearch in Google Scholar

Empfohlene Artikel von Trend MD